The Safety and Efficacy of XytriX (Umbilical Cord-Derived Mesenchymal Stem Cells) in the Treatment of Knee Osteoarthritis

ConditionOsteoarthritis

Trial statusNot yet recruiting

Trial phasePhase 1, Phase 2

Trial typeInterventional

Biological sexAll

Age18+

SponsorTricelX Inc.

About this trial

This study aims to study the safety and efficacy of XytriX, an umbilical cord-derived stem cell product, in the treatment of Grade I-IV knee osteoarthritis.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

Mesenchymal Stem Cell Injection

Treatment groups

75 Participants

are divided into 3 treatment groups

Sponsors and collaborators

TricelX Inc.

Lead sponsor

Source ClinicalTrials.gov